E
Telomir Pharmaceuticals, Inc. TELO
$4.58 -$0.45-8.95%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -26.48% -442.61% -580.57% -1,383.39% -1,430.30%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges 169.20% 485.65% 4,598.47% -- --
Total Other Non-Cash Items -6.54% 90,851.85% 7,486,600.00% -- --
Change in Net Operating Assets 10.97% -84.82% -173.78% 161.86% -70.45%
Cash from Operations -31.36% -83.32% -491.67% -344.52% -723.69%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -100.00% -53.48% 240.29% 693.18% 573.79%
Total Debt Repaid -- -211.46% -- -- --
Issuance of Common Stock 530.30% 461.42% 461.42% 461.42% 1,881.82%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -94.75% 75.84% -64.40% -441.23%
Cash from Financing 64.14% 111.08% 656.42% 633.42% 721.02%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 632,550.00% 21,438.46% 31,583.05% 131,000.00% -113.33%
Weiss Ratings